Reference data : LOINC code

Filter


Clear filter

Results
108,248 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType <span class='defaultText'>DefinitionDescription</span> dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
14886-6 Pregnanetriol SRat Urine 24H Qn &nbsp; &nbsp; ACTIVE Pregnanetriol [Moles/time] in 24 hour Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/d &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14886-6 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Pregntrl 24h Ur-sRate &nbsp; &nbsp; &nbsp; Y &nbsp; 1 day; 24 hours; 24HR; Chemistry; Pregnanetr; Pregntrl; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn 2.58 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/(24.h) &nbsp; &nbsp; &nbsp; 0
14887-4 Primidone SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Primidone [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14887-4 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Primidone SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; DRUG/TOXICOLOGY; Drugs; Level; Mysoline; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
14888-2 Procainamide SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Procainamide [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14888-2 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Procainamide SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; DRUG/TOXICOLOGY; Drugs; Level; PA; Pl; Plasma; Plsm; Point in time; Procan; Pronestyl; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
14889-0 Procainamide+N-acetylprocainamide SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Procainamide+N-acetylprocainamide [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14889-0 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Procainamide+NAPA SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Acecainide; Acetylprocanam; DRUG/TOXICOLOGY; Drugs; Level; NAPA; PA; Pl; Plasma; Plsm; Point in time; Procainamide+NAPA; Procan; Pronestyl; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
1489-4 Gastrin^5M post 0.2 U/kg secretin MCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Gastrin [Mass/volume] in Serum or Plasma --5 minutes post 0.2 U/kg secretin &nbsp; MIN DefinitionDescription &nbsp; &nbsp; pg/mL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 1489-4 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Gastrin 5M p 0.2 u/kg SCT SerPl-mCnc &nbsp; &nbsp; &nbsp; Y &nbsp; 5M p 0.2 u/kg SCT; After; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Total gastrins; Zollinger-Ellison syndrome 2.34 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pg/mL &nbsp; &nbsp; &nbsp; 0
14890-8 Progesterone SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Progesterone [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14890-8 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Progest SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Chemistry; Level; P4; Pl; Plasma; Plsm; Point in time; Prog; Proges; Progest; Progestin; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; 0
14891-6 Propranolol SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Propranolol [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14891-6 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Propranolol SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; DRUG/TOXICOLOGY; Drugs; Inderal; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
14892-4 Propranolol SCnc Urine Pt Qn &nbsp; &nbsp; ACTIVE Propranolol [Moles/volume] in Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14892-4 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Propranolol Ur-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; DRUG/TOXICOLOGY; Drugs; Inderal; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn 2.42 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/L &nbsp; &nbsp; &nbsp; 0
14893-2 Propranolol SRat Urine 24H Qn &nbsp; &nbsp; ACTIVE Propranolol [Moles/time] in 24 hour Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/24 H &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14893-2 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Propranolol 24h Ur-sRate &nbsp; &nbsp; &nbsp; Y &nbsp; 1 day; 24 hours; 24HR; DRUG/TOXICOLOGY; Drugs; Inderal; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn 2.42 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/(24.h) &nbsp; &nbsp; &nbsp; 0
14894-0 Propylene glycol PrThr Ser/Plas Pt Ord &nbsp; &nbsp; ACTIVE Propylene glycol [Presence] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14894-0 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Prop glycol SerPl Ql &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOXICOLOGY; Drugs; Ordinal; Pl; Plasma; Plsm; Point in time; PR; Prop glycol; Ql; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.56 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14895-7 Protein pattern Imp Ser/Plas Pt Nom Immunofixation &nbsp; ACTIVE Protein Fractions [Interpretation] in Serum or Plasma by Immunofixation &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14895-7 &nbsp; Immunofixation &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Prot Pattern SerPl IFE-Imp &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Chemistry; IFE; Ifix; Immunofixation electrophoresis; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Pl; Plasma; Plsm; Point in time; PR; Prot; Prot Pattern; Protein fractions; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
14896-5 Protein pattern Imp Urine Pt Nom Immunofixation &nbsp; ACTIVE Protein Fractions [Interpretation] in Urine by Immunofixation &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14896-5 &nbsp; Immunofixation &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Prot Pattern Ur IFE-Imp &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Chemistry; Hematology; Heme; IFE; Ifix; Immunofixation electrophoresis; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Kidney; Nephrology; Nominal; Point in time; PR; Prot; Prot Pattern; Protein fractions; Random; Renal; UA; UR; Urn 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
14897-3 Protein MCnc Plas Pt Qn &nbsp; &nbsp; DEPRECATED Deprecated Protein [Mass/volume] in Plasma &nbsp; DEL DefinitionDescription &nbsp; &nbsp; g/dL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14897-3 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0 Deprecated Prot Plas-mCnc &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random 2.4 1.0k &nbsp; &nbsp; &nbsp; AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
14898-1 Protriptyline SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Protriptyline [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14898-1 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Protrip SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Vivactil 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
14899-9 quiNIDine SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE quiNIDine [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14899-9 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 quiNIDine SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Chinidine; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.34 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
149-5 Cephalexin Susc Isolate Pt OrdQn MIC &nbsp; ACTIVE Cephalexin [Susceptibility] by Minimum inhibitory concentration (MIC) &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 149-5 &nbsp; MIC &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Cephalexin Islt MIC &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefadine; GRACEF; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Keflex; Losporal; Minimum inhibitory concentration; Palitrex; Point in time; Random; Salitex; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.19 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
1490-2 Gastrin^pre 0.2 U/kg secretin MCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Gastrin [Mass/volume] in Serum or Plasma --pre 0.2 U/kg secretin &nbsp; MIN DefinitionDescription &nbsp; &nbsp; pg/mL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHAL &nbsp; 1490-2 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Gastrin pre 0.2 u/kg SCT SerPl-mCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Before; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; pre 0.2 u/kg SCT; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Total gastrins; Zollinger-Ellison syndrome 2.73 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; pg/mL &nbsp; &nbsp; &nbsp; 0
14900-5 raNITIdine PrThr Gast fld Pt Ord &nbsp; &nbsp; ACTIVE raNITIdine [Presence] in Gastric fluid &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14900-5 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 raNITIdine Gast Ql &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Zantac 2.56 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14901-3 raNITIdine PrThr Ser/Plas Pt Ord &nbsp; &nbsp; ACTIVE raNITIdine [Presence] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14901-3 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 raNITIdine SerPl Ql &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOXICOLOGY; Drugs; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Zantac 2.56 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14902-1 raNITIdine PrThr Urine Pt Ord &nbsp; &nbsp; ACTIVE raNITIdine [Presence] in Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 14902-1 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 raNITIdine Ur Ql &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn; Zantac 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14903-9 Folate Imp Bld Pt Nom &nbsp; &nbsp; ACTIVE Folate [Interpretation] in Blood &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14903-9 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Folate Bld-Imp &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Blood; Chemistry; Folat; Folic acid; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Pteroylglutamate; Pteroylglutamic acid; Random; Vit M; Vitamin M; WB; Whole blood 2.26 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
14904-7 Reagin Ab PrThr XXX Pt Ord VDRL &nbsp; ACTIVE Reagin Ab [Presence] in Specimen by VDRL &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MICRO &nbsp; 14904-7 &nbsp; VDRL &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 VDRL Spec Ql &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; Microscopic flocculation; Misc; Miscellaneous; Neurosyphilis; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Syphilis; To be specified in another part of the message; Treponema; Unspecified; Venereal Disease Research Laboratory 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14905-4 Retinol SCnc Ser/Plas Pt Qn &nbsp; &nbsp; ACTIVE Retinol [Moles/volume] in Serum or Plasma &nbsp; MIN DefinitionDescription &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 14905-4 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Vit A SerPl-sCnc &nbsp; &nbsp; &nbsp; Y &nbsp; Axerol; Axerophthol; Biosterol; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Vit A; Vit A alcohol; Vit A1; Vit A1 alcohol; Vitamin A; Vitamin A alcohol; Vitamin A1 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; umol/L &nbsp; &nbsp; &nbsp; 0
14906-2 Rh Type BldCo Pt Nom &nbsp; &nbsp; ACTIVE Rh [Type] in Cord blood &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; BLDBK &nbsp; 14906-2 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Rh BldCo &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Blood - (umbilical) cord; BLOOD BANK; Cord (umbilical) blood; Cord bld; Cord blood; D phenotyping; D typing; Gyn; Gynecology; Hematology; Heme; Nominal; OB; ObGyn; Obstetrics; Point in time; Random; Rh phenotyping; Rh typing; Typ 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
14907-0 Rh Type Bld^BPU Pt Nom &nbsp; &nbsp; ACTIVE Rh [Type] in Blood from Blood product unit &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; BLDBK &nbsp; 14907-0 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Rh Bld BPU &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Blood; BLOOD BANK; Blood product unit; Blood Product Unit (Pack); D phenotyping; D typing; Hematology; Heme; Nominal; Point in time; Random; Rh phenotyping; Rh typing; Typ; WB; Whole blood 2.73 1.0k &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
108,248 results found